BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mitre A, Florian AI, Buruiana A, Boer A, Moldovan I, Soritau O, Florian SI, Susman S. Ferroptosis Involvement in Glioblastoma Treatment. Medicina 2022;58:319. [DOI: 10.3390/medicina58020319] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Lu Q, Lu X, Zhang Y, Huang W, Zhou H, Li T. Recent advances in ferroptosis and therapeutic strategies for glioblastoma. Front Mol Biosci 2023;9. [DOI: 10.3389/fmolb.2022.1068437] [Reference Citation Analysis]
2 Zhang M, Lei Q, Huang X, Wang Y. Molecular mechanisms of ferroptosis and the potential therapeutic targets of ferroptosis signaling pathways for glioblastoma. Front Pharmacol 2022;13:1071897. [PMID: 36506514 DOI: 10.3389/fphar.2022.1071897] [Reference Citation Analysis]
3 Wu H, He H, Huang J, Wang C, Dong Y, Lin R, Cheng Z, Qiu Q, Hong L. Identification and validation of transferrin receptor protein 1 for predicting prognosis and immune infiltration in lower grade glioma. Front Mol Neurosci 2022;15. [DOI: 10.3389/fnmol.2022.972308] [Reference Citation Analysis]
4 Luo Y, Tian G, Fang X, Bai S, Yuan G, Pan Y. Ferroptosis and Its Potential Role in Glioma: From Molecular Mechanisms to Therapeutic Opportunities. Antioxidants 2022;11:2123. [DOI: 10.3390/antiox11112123] [Reference Citation Analysis]
5 Su X, Xie Y, Zhang J, Li M, Zhang Q, Jin G, Liu F. HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis. Cell Death Dis 2022;13:861. [PMID: 36209275 DOI: 10.1038/s41419-022-05304-8] [Reference Citation Analysis]
6 de Souza I, Monteiro LKS, Guedes CB, Silva MM, Andrade-Tomaz M, Contieri B, Latancia MT, Mendes D, Porchia BFMM, Lazarini M, Gomes LR, Rocha CRR. High levels of NRF2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1/MRP1 upregulation. Cell Death Dis 2022;13:591. [PMID: 35803910 DOI: 10.1038/s41419-022-05044-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Zhang X, Chen Q, Li Y, Chen H, Jiang Q, Hu Q, Xu Y. N-myc Downstream-Regulated Gene 1 (NDRG1) Regulates Vascular Endothelial Growth Factor A (VEGFA) and Malignancies in Glioblastoma Multiforme (GBM). BioMed Research International 2022;2022:1-9. [DOI: 10.1155/2022/3233004] [Reference Citation Analysis]
8 Neag MA, Mitre AO, Burlacu CC, Inceu AI, Mihu C, Melincovici CS, Bichescu M, Buzoianu AD. miRNA Involvement in Cerebral Ischemia-Reperfusion Injury. Front Neurosci 2022;16:901360. [PMID: 35757539 DOI: 10.3389/fnins.2022.901360] [Reference Citation Analysis]
9 de Souza I, Ramalho MCC, Guedes CB, Osawa IYA, Monteiro LKS, Gomes LR, Rocha CRR. Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment. IJMS 2022;23:6879. [DOI: 10.3390/ijms23136879] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]